About UCL


Located in central London, UCL (University College London) is renowned for its pioneering research, which spans the sciences, social sciences, biomedicine, humanities and arts. ‘About UCL’ provides a quick guide to the university and shows how it is using its wide-ranging expertise to tackle some of the world’s major problems. Video narration by UCL alum Jonathan Dimbleby

Creation In The 21st Century – How to Talk to an Evolutionist About Creation 1 of 3


Carl Baugh talks with Dr. Carl Jackson about what to tell hand how to tell an evolutionist about creation. Dr. Carl Jackson — PHD in science education — from the University of Virginia — History that covers evolutionary theory — Has a creation ministry — Works in micro biology and biochemistry Four Great Questions of Life/Existence/Being 1. Who am I? 2. Where did I come from? 3. What’s My Purpose Here? 4. Where am I going? Where did I come from? — If Evolution is true — We came from a rock What’s My Purpose Here? — If Evolution is true — We have no purpose Where am I going? — If Evolution is true — We aren’t going anywhere and there is no eternal future Where did I come from? — If Creation is true — We were created by a loving, beneficent, divine, all wise creator What’s My Purpose Here? — If Creation is true — We have a purpose to represent him Where am I going? — If Creation is true — We have a glorious future to know him face to face How should you talk to an evolutionist about the issues of life and about creation — without offending that individual? When you are talking to an evolutionist about creation — you should be praying in your mind You should understand what they are thinking first — Apostle Paul did that — see where they are coming from Some evolutionist are persuaded that there is evidence showing evolutionary theory Others are compelled that evolution must be true Even Church members might believe in evolution Richard Dawkins — Said

AT Shulgin – How i go about discovering new drugs (1998) [3/5]


A talk by Alexander T. Shulgin @ Psychoactivity Conference, Amsterdam. “Alexander “Sasha” Shulgin, Ph.D., is a pharmacologist and chemist known for his creation of new psychoactive chemicals. After serving in the Navy, he earned his Ph.D. in Biochemistry from UC Berkeley in 1954. In the late 50s and early 60s he did post-doctorate work in psychiatry and pharmacology at UC San Francisco and worked briefly as research director at BioRad Laboratories before becoming a senior research chemist at Dow Chemical Co. In 1960, Sasha tried mescaline for the first time. He then experimented with synthesizing chemicals with structures similar to mescaline such as DOM. After leaving Dow in 1965 to become an independent consultant, Sasha taught public health at Berkeley and San Francisco General Hospital. In 1967, he was introduced to the possibilities of MDMA by an undergrad at San Francisco State University at a time when very few people had tried MDMA. Though Shulgin didn’t invent the chemical, he did create a new synthesis process in 1976 and introduced the material to Leo Zeff, an Oakland psychologist who worked with psychedelics in his therapy practice. Zeff introduced hundreds of therapists to MDMA and word quickly spread outside the therapist community. Sasha’s partner Ann Shulgin also conducted psychedelic therapy sessions with MDMA before it was scheduled in 1985. Since that time, Shulgin has synthesized and bioassayed (self-tested) hundreds of psychoactive chemicals

Genencor – It’s All About You


Genencor is amongst the largest developers and manufacturers of industrial enzymes and the second largest biotechnology company in the world. Genencor discovers, develops, manufactures, and delivers eco-friendly, efficient enzyme product solutions for the agri processing, cleaning and textiles, food and feed, consumer, and industrial markets. We also develop innovative advancements for the biofuels, biodefense, and biosafety industries. We are a recognized leader in protein and pathway engineering. No other biotechnology company offers the breadth of skills and experience that we do to deliver total solutions to a broad array of markets.

AT Shulgin – How i go about discovering new drugs (1998) [1/5]


A talk by Alexander T. Shulgin @ Psychoactivity Conference, Amsterdam. “Alexander “Sasha” Shulgin, Ph.D., is a pharmacologist and chemist known for his creation of new psychoactive chemicals. After serving in the Navy, he earned his Ph.D. in Biochemistry from UC Berkeley in 1954. In the late 50s and early 60s he did post-doctorate work in psychiatry and pharmacology at UC San Francisco and worked briefly as research director at BioRad Laboratories before becoming a senior research chemist at Dow Chemical Co. In 1960, Sasha tried mescaline for the first time. He then experimented with synthesizing chemicals with structures similar to mescaline such as DOM. After leaving Dow in 1965 to become an independent consultant, Sasha taught public health at Berkeley and San Francisco General Hospital. In 1967, he was introduced to the possibilities of MDMA by an undergrad at San Francisco State University at a time when very few people had tried MDMA. Though Shulgin didn’t invent the chemical, he did create a new synthesis process in 1976 and introduced the material to Leo Zeff, an Oakland psychologist who worked with psychedelics in his therapy practice. Zeff introduced hundreds of therapists to MDMA and word quickly spread outside the therapist community. Sasha’s partner Ann Shulgin also conducted psychedelic therapy sessions with MDMA before it was scheduled in 1985. Since that time, Shulgin has synthesized and bioassayed (self-tested) hundreds of psychoactive chemicals